argus

AstraZeneca Pharma India Ltd.

NSE: ASTRAZENINE203A01020₹17,345 Cr

Timeline

Time (IST)TypeMEventSrc
07 Nov, 06:35 pm—…AstraZeneca Pharma India Limited has informed the Exchange regarding a press release dated November 07, 2025, titled "Press Release".nse
07 Nov, 06:25 pm—…AstraZeneca Pharma India Ltd - 506820 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
07 Nov, 05:45 pm—…AstraZeneca Pharma India Ltd - 506820 - Outcome Of The Board Meeting Held On Friday, November 7, 2025bse
07 Nov, 05:38 pm—…AstraZeneca Pharma India Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.nse
27 Oct, 10:41 am—…AstraZeneca Pharma India Ltd - 506820 - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Friday, November 7, 2025bse
15 Oct, 02:35 pm—…AstraZeneca Pharma India Limited has informed the Exchange about Product launchnse
15 Oct, 02:34 pm—…AstraZeneca Pharma India Ltd - 506820 - Launch Of Sodium Zirconium Cyclosilicate Powder For Oral Suspension 5G (Lokelma)bse
03 Oct, 08:39 pm—…AstraZeneca Pharma India Limited has informed the Exchange about Product launchnse
03 Oct, 08:31 pm—…AstraZeneca Pharma India Ltd - 506820 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015bse
19 Sept, 10:01 am—…AstraZeneca Pharma India Limited has informed the Exchange about General Updatesnse
19 Sept, 09:52 am—…AstraZeneca Pharma India Ltd - 506820 - Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
12 Sept, 02:54 pm—…AstraZeneca Pharma India Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Companynse
12 Sept, 02:39 pm—…AstraZeneca Pharma India Ltd - 506820 - Disclosure under Regulation 30A of LODRbse
12 Sept, 02:37 pm—…AstraZeneca Pharma India Limited has informed regarding Disclosure of material issue under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015nse
12 Sept, 02:35 pm—…AstraZeneca Pharma India Limited has informed regarding Disclosure of material issuense
10 Sept, 07:41 pm—…AstraZeneca Pharma India Limited has informed the Exchange regarding 'Legible copy of the un-audited financial results for the quarter ended June 30, 2025'.nse
02 Sept, 05:38 pm—…AstraZeneca Pharma India Limited has informed the Exchange about General Updatesnse
02 Sept, 05:37 pm—…AstraZeneca Pharma India Limited has informed regarding Disclosure of material issuense
02 Sept, 05:35 pm—…AstraZeneca Pharma India Limited has informed regarding Disclosure of material issuense
02 Sept, 05:30 pm—…AstraZeneca Pharma India Ltd - 506820 - Disclosure under Regulation 30A of LODRbse
01 Sept, 08:01 pm—…AstraZeneca Pharma India Ltd - 506820 - Disclosure under Regulation 30A of LODRbse
01 Sept, 08:00 pm—…AstraZeneca Pharma India Limited has informed the Exchange about Credit Ratingnse